| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/04/2002 | WO2002026995A1 Herbicide resistant plants |
| 04/04/2002 | WO2002026994A1 Manipulation of plant cell walls |
| 04/04/2002 | WO2002026988A2 Human drug metabolizing enzymes |
| 04/04/2002 | WO2002026984A2 Potassium channel interactors and uses therefor |
| 04/04/2002 | WO2002026982A2 Secreted human proteins |
| 04/04/2002 | WO2002026977A1 Host cell obtained by transferring vhl gene into cancer cell or embryonic stem cell and expressing |
| 04/04/2002 | WO2002026976A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility |
| 04/04/2002 | WO2002026954A2 Truncated phosphodiesterase-7 polypeptides |
| 04/04/2002 | WO2002026951A2 Oxidoreductases |
| 04/04/2002 | WO2002026950A2 Transferases |
| 04/04/2002 | WO2002026947A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | WO2002026946A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/04/2002 | WO2002026942A2 Human liver cell line |
| 04/04/2002 | WO2002026941A2 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 04/04/2002 | WO2002026940A1 Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells |
| 04/04/2002 | WO2002026939A2 Microfabrication of membranes for the growth of cells |
| 04/04/2002 | WO2002026929A2 Kini-3 motor protein and methods for its use |
| 04/04/2002 | WO2002026832A1 Antibodies for human cytochrome p450 2d6 |
| 04/04/2002 | WO2002026825A2 G-protein coupled receptors |
| 04/04/2002 | WO2002026822A2 Pumpcn compositions and uses thereof |
| 04/04/2002 | WO2002026805A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | WO2002026778A2 Isolated peptides which bind to hla-c molecules and uses thereof |
| 04/04/2002 | WO2002026616A1 Microscopic networks of containers and nanotubes |
| 04/04/2002 | WO2002026209A2 Microparticles for delivery of the heterologous nucleic acids |
| 04/04/2002 | WO2002026192A2 Viruses targeted to hypoxic cells and tissues |
| 04/04/2002 | WO2002026116A2 Repair and regeneration of cartilage, collagen and bone remodeling |
| 04/04/2002 | WO2002008435A8 Codon-optimized papilloma virus sequences |
| 04/04/2002 | WO2002004598A3 Improvement of cell culture performance by inhibitors of pyruvate dehydrogenase kinase |
| 04/04/2002 | WO2001094544A3 N.bstnbi nicking endonuclease and methods for using endonucleases in single-stranded displacement amplification |
| 04/04/2002 | WO2001090306A3 Compositions and methods for modulating tumor specific expression |
| 04/04/2002 | WO2001088106A3 Novel deoxyribonucleside kinase enzyme multi-substrate variants |
| 04/04/2002 | WO2001087237A3 Apparatus and process for in situ manufacture of essence from living, uncut plants |
| 04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
| 04/04/2002 | WO2001085921A3 Human serine-threonine kinase-4 |
| 04/04/2002 | WO2001083714A3 Composition and methods for treating photoreceptor degeneration |
| 04/04/2002 | WO2001082954A3 Ceruloplasmin and uses thereof in neurodegenerative related conditions |
| 04/04/2002 | WO2001075067A3 Novel nucleic acids and polypeptides |
| 04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 04/04/2002 | WO2001072846A3 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 04/04/2002 | WO2001072839A3 Human g-protein coupled receptors |
| 04/04/2002 | WO2001072829A3 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 04/04/2002 | WO2001072781A3 Human genes and expression products |
| 04/04/2002 | WO2001068695A3 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 04/04/2002 | WO2001066741A3 Kcnb: a novel potassium channel protein |
| 04/04/2002 | WO2001064896A3 Human enzyme molecules |
| 04/04/2002 | WO2001062778A3 Tumour-specific animal proteins |
| 04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 04/04/2002 | WO2001053352A3 Sperm specific proteins |
| 04/04/2002 | WO2001051616A3 Techniques for growth and differentiation of human pluripotent stem cells |
| 04/04/2002 | WO2001050848A3 Clonal propagation of primate offspring by embryo splitting |
| 04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
| 04/04/2002 | WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/04/2002 | WO2001012777A9 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 04/04/2002 | WO2000072021A3 Cancer associated antigens and uses therefor |
| 04/04/2002 | WO2000070099A3 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 04/04/2002 | WO2000058359A9 Retro-inverso prosaposin-derived peptides and use thereof |
| 04/04/2002 | US20020040488 Synthases |
| 04/04/2002 | US20020040485 Transgenic systems for the manufacture of poly(2-hydroxy-butyrate-co-3-hydroxyhexanoate) |
| 04/04/2002 | US20020040484 Administering to cell a compound capable of modulating protein complex having a first protein which is delta -catenin interacting with a second protein which is FAK2 |
| 04/04/2002 | US20020040130 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 04/04/2002 | US20020040127 Nucleotide sequences which code tumor protein for use in diagnosis, prevention and treament of tumors |
| 04/04/2002 | US20020040009 Novel ratA |
| 04/04/2002 | US20020040000 Human kcnq5 potassium channel, methods and compositions thereof |
| 04/04/2002 | US20020039995 Administering to mammal in need of such treatment a therapeutically effective amount of a trkB or trkC agonist |
| 04/04/2002 | US20020039991 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | US20020039790 Adjustment of immunology of cells |
| 04/04/2002 | US20020039789 Method for production of neuroblasts |
| 04/04/2002 | US20020039788 Xenogenic exograft for use in the treatment of vision defects |
| 04/04/2002 | US20020039787 Method for culturing cells |
| 04/04/2002 | US20020039786 Generating progenitor cells; provide cells for organ grafting, propagate cells, recover cells |
| 04/04/2002 | US20020039780 Salicyclic acid inducible genes and promoters |
| 04/04/2002 | US20020039779 Transcriptional regulator |
| 04/04/2002 | US20020039765 Viral polypeptide for use as tool in genetic engineering and gene therapy |
| 04/04/2002 | US20020039763 Interferon-like protein Zcyto21 |
| 04/04/2002 | US20020039746 Methods for identifying peripheral benzodiazepine receptor binding agents |
| 04/04/2002 | US20020039724 Neural progenitor cell populations |
| 04/04/2002 | US20020039585 Mutants of streptococcal toxin c and methods of use |
| 04/04/2002 | US20020039583 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/04/2002 | US20020039580 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification |
| 04/04/2002 | US20020039569 Activation; separation |
| 04/04/2002 | DE10047272A1 Verfahren zur Fusion von dendritischen Zellen mit erkrankten Gewebezellen, insbesondere Tumorzellen und Medien für solche Verfahren Process for the fusion of dendritic cells with diseased tissue cells, particularly tumor cells and media for such methods |
| 04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
| 04/04/2002 | CA2424309A1 Method for in vivo, ex vivo and in vitro repair and regeneration of cartilage and collagen and bone remodeling |
| 04/04/2002 | CA2424062A1 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 04/04/2002 | CA2423991A1 Pumpcn compositions and uses thereof |
| 04/04/2002 | CA2423955A1 Kini-3 motor protein and methods for its use |
| 04/04/2002 | CA2423953A1 Hydrolases |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423701A1 Oxidoreductases |
| 04/04/2002 | CA2423694A1 Transferases |
| 04/04/2002 | CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | CA2423446A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2422530A1 Human drug metabolizing enzymes |
| 04/04/2002 | CA2421680A1 Antibodies for human cytochrome p450 2d6 |
| 04/04/2002 | CA2421620A1 Promoter sequences |
| 04/04/2002 | CA2420960A1 Potassium channel interactors and uses therefor |
| 04/03/2002 | EP1193311A1 Method for stimulating the mating of microorganisms in liquid medium |
| 04/03/2002 | EP1193272A1 Single-chain insulin analogs |